Search Result "JAK2 Inhibitors"
Analogs of Cinnamic Acid Benzyl Amide As Nonclassical Inhibitors of Activated JAK2 Kinase
Journal: Current Cancer Drug Targets
Volume: 14 Issue: 7 Year: 2014 Page: 638-651
Author(s): Marcin Mielecki,MaÅgorzata Milner-Krawczyk,Krystyna Grzelak,Damian Mielecki,Krystiana A. Krzysko,Bogdan Lesyng,Waldemar Priebe
The Recent Medicinal Chemistry Development of Jak2 Tyrosine Kinase Small Molecule Inhibitors
Journal: Current Medicinal Chemistry
Volume: 17 Issue: 3 Year: 2010 Page: 4551-4558
Author(s): R. Baskin, A. Majumder, P. P. Sayeski
Insights into the Structural Features Essential for JAK2 Inhibition and Selectivity
Journal: Current Medicinal Chemistry
Volume: 23 Issue: 13 Year: 2016 Page: 1331-1355
Author(s): Chao Zhao,Daulat Bikram Khadka,Won-Jea Cho
JAK2 Inhibitors for Myelofibrosis: Why are They Effective in Patients with and Without JAK2V617F Mutation?
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12 Issue: 9 Year: 2012 Page: 1098-1109
Author(s): Fabio P. S. Santos,Srdan Verstovsek
JAK2 as a Molecular Marker in Myeloproliferative Diseases
Journal: Cardiovascular & Hematological Agents in Medicinal Chemistry
Volume: 5 Issue: 3 Year: 2007 Page: 198-203
Author(s): R. Mata, D. Subira, A. Garcia-Raso, P. Llamas
The Relevance of JAK2 in the Regulation of Cellular Transport
Journal: Current Medicinal Chemistry
Volume: 23 Issue: 6 Year: 2016 Page: 578-588
Author(s): Mentor Sopjani,Vjollca Konjufca,Mark Rinnerthaler,Rexhep Rexhepaj,Miribane Dërmaku-Sopjani
A Structure-Function Perspective of Jak2 Mutations and Implications for Alternate Drug Design Strategies: The Road not Taken
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 3 Year: 2011 Page: 4659-4673
Author(s): K. Gnanasambandan, P.P. Sayeski
Jak2 Tyrosine Kinase and Cancer: How Good Cells Get HiJAKed
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 7 Issue: 6 Year: 2007 Page: 643-650
Author(s): Michael D. Godeny, Peter P. Sayeski
Jak2 and Reactive Oxygen Species: A Complex Relationship
Journal: Current Chemical Biology
Volume: 1 Issue: 3 Year: 2007 Page: 303-310
Author(s): Issam McDoom, Peter P. Sayeski
Preclinical Metabolism and Pharmacokinetics of SB1317 (TG02), a Potent CDK/JAK2/FLT3 Inhibitor
Journal: Drug Metabolism Letters
Volume: 6 Issue: 1 Year: 2012 Page: 33-42
Author(s): Mohammed Khalid Pasha, Ramesh Jayaraman, Venkatesh Pilla Reddy, Pauline Yeo, Evelyn Goh,Anthony Williams, Kee Chuan Goh, Ethirajulu Kantharaj